Canada Rejects 300,000 Doses of J&J Vaccine Made in U.S.

The New York Times | June 12, 2021, 11:28 a.m. | Original

The Canadian regulator also banned the use of all products made at Emergent BioSolutions’ plant in Baltimore, Md., until it conducts an on-site inspection.T

Flushing taps, washing hands: Experts have advice for reopening offices safely. In Myanmar, Health Care’s Collapse Takes Its Own Toll